{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T10:23:35Z","timestamp":1649067815833},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Herzschr. Elektrophys."],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s00399-009-0046-5","type":"journal-article","created":{"date-parts":[[2010,6,17]],"date-time":"2010-06-17T17:20:13Z","timestamp":1276795213000},"page":"61-69","source":"Crossref","is-referenced-by-count":0,"title":["Thromboembolieprophylaxe bei Vorhofflimmern"],"prefix":"10.1007","volume":"20","author":[{"given":"H.","family":"Volkmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Krpciar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Vetter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,6,20]]},"reference":[{"key":"46_CR1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9343(98)00198-3","volume":"105","author":"Beyth","year":"1998","unstructured":"Beyth RJ, Quinn LM, Landefeld CS (1998) Prospective evaluation of an index for predicting risk of major bleeding in outpatients treated with warfarin. Am J Med 105:91\u201399","journal-title":"Am J Med"},{"key":"46_CR2","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.hrthm.2007.04.005","volume":"4","author":"Calkins","year":"2007","unstructured":"Calkins H, Brugada J, Packer DL et al (2007) HRA\/EHRA\/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. Heart Rhythm 4:816\u2013861","journal-title":"Heart Rhythm"},{"key":"46_CR3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0735-1097(91)90585-W","volume":"18","author":"Connolly","year":"1991","unstructured":"Connolly SJ, Laupacis A, Gent M et al (1991) Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 18:349\u2013355","journal-title":"J Am Coll Cardiol"},{"key":"46_CR4","unstructured":"Connolly SJ, Pogue J, Hart RG, Hohnloser SH (2009) Effect of clopidogrel added to aspirin in patients with atrial fibrillation: The ACTIVE investigators. N Engl J Med 360"},{"key":"46_CR5","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/0140-6736(93)92358-Z","volume":"342","author":"EAFT","year":"1993","unstructured":"EAFT (European Atrial Fibrillation Trial) Study Group (1993) Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 342:1255\u20131262","journal-title":"Lancet"},{"key":"46_CR6","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199211123272002","volume":"327","author":"Ezekowitz","year":"1992","unstructured":"Ezekowitz MD, Bridgers SL, James KE et al (1992) Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans affairs stroke prevention in nonrheumatic atrial fibrillation investigators. N Engl J Med 327:1406\u20131412","journal-title":"N Engl J Med"},{"key":"46_CR7","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ehj.2004.04.015","volume":"25","author":"Fetsch","year":"2004","unstructured":"Fetsch T, Bauer P, Engberding R et al (2004) Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. Eur Heart J 25:1385\u20131394","journal-title":"Eur Heart J"},{"key":"46_CR8","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1093\/eurheartj\/ehl176","volume":"27","author":"Fuster","year":"2006","unstructured":"Fuster V, Ryden LE, Cannom DS et al (2006) ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation \u2013 executive summary. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J 27:1979\u20132030","journal-title":"Eur Heart J"},{"key":"46_CR9","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","volume":"285","author":"Gage","year":"2001","unstructured":"Gage BF, Waterman AD, Shannon W et al (2001) Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285:2864\u20132870","journal-title":"JAMA"},{"key":"46_CR10","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-131-7-199910050-00003","volume":"131","author":"Hart","year":"1999","unstructured":"Hart RG, Benavente O, McBride R, Pearce LA (1999) Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 131:492\u2013501","journal-title":"Ann Intern Med"},{"key":"46_CR11","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1161\/01.STR.32.3.803","volume":"32","author":"Hart","year":"2001","unstructured":"Hart RG, Halperin JL (2001) Atrial fibrillation and stroke: concepts and controversies. Stroke 32:803\u2013808","journal-title":"Stroke"},{"key":"46_CR12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0735-1097(99)00489-1","volume":"35","author":"Hart","year":"2000","unstructured":"Hart RG, Pearce LA, Rothbart RM et al (2000) Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. J Am Coll Cardiol 35:183\u2013187","journal-title":"J Am Coll Cardiol"},{"key":"46_CR13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1161\/CIRCULATIONAHA.104.518837","volume":"112","author":"Hindricks","year":"2005","unstructured":"Hindricks G, Piorkowski C, Tanner H et al (2005) Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence. Circulation 112:307\u2013313","journal-title":"Circulation"},{"key":"46_CR14","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1046\/j.1540-8167.2004.04524.x","volume":"15","author":"Hocini","year":"2004","unstructured":"Hocini M, Sanders P, Jais P et al (2004) Techniques for curative treatment of atrial fibrillation. J Cardiovasc Electrophysiol 15:1467\u20131471","journal-title":"J Cardiovasc Electrophysiol"},{"key":"46_CR15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/eurheartj\/sun029","volume":"10","author":"Hohnloser","year":"2008","unstructured":"Hohnloser SH, Duray GZ, Baber U, Halperin JL (2008) Prevention of stroke in patients with atrial fibrillation: current strategies and future directions. Eur Heart J 10(Suppl H):4\u201310","journal-title":"Eur Heart J"},{"key":"46_CR16","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJM200105103441901","volume":"344","author":"Klein","year":"2001","unstructured":"Klein AL, Grimm RA, Murray RD et al (2001) Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 344:1411\u20131420","journal-title":"N Engl J Med"},{"key":"46_CR17","first-page":"4","volume":"2","author":"Konstantinides","year":"2008","unstructured":"Konstantinides S (2008) Antithrombotische Therapie bei Vorhofflimmern. Thromboembolie 2:4\u20137","journal-title":"Thromboembolie"},{"key":"46_CR18","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.hrthm.2005.06.026","volume":"2","author":"Lemola","year":"2005","unstructured":"Lemola K, Desjardins B, Sneider M et al (2005) Effect of left atrial circumferential ablation for atrial fibrillation on left atrial transport function. Heart Rhythm 2:923\u2013928","journal-title":"Heart Rhythm"},{"key":"46_CR19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s12181-008-0080-2","volume":"2","author":"Lewalter","year":"2008","unstructured":"Lewalter T, Tebbenjohanns J, Wichter T et al (2008) Kommentar zu \u201eACC\/AHA\/ESC 2006 Guidelines fort he management of patients with atrial fibrillation \u2013 executive summary\u201c. Kardiologe 2:181\u2013205","journal-title":"Kardiologe"},{"key":"46_CR20","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S1474-4422(07)70264-8","volume":"6","author":"Lip","year":"2007","unstructured":"Lip GYH, Lim HS (2007) Atrial fibrillation and stroke prevention. Lancet Neurol 6:981\u2013993","journal-title":"Lancet Neurol"},{"key":"46_CR21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","volume":"370","author":"Mant","year":"2007","unstructured":"Mant J, Hobbs FDR, Fletcher K et al (2007) Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 370:493\u2013503","journal-title":"Lancet"},{"key":"46_CR22","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1055\/s-2006-957212","volume":"131","author":"Mewis","year":"2006","unstructured":"Mewis C, Neuberger HR, B\u00f6hm M (2006) Vorhofflimmern. Dtsch Med Wochenschr 131:2843\u20132854","journal-title":"Dtsch Med Wochenschr"},{"key":"46_CR23","doi-asserted-by":"crossref","first-page":"36D","DOI":"10.1016\/S0002-9149(00)00905-X","volume":"85","author":"Naccarelli","year":"2000","unstructured":"Naccarelli GV, Dell\u2019Orfano JT, Wolbrett DL et al (2000) Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy. Am J Cardiol 85:36D\u201345D","journal-title":"Am J Cardiol"},{"key":"46_CR24","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/CIRCULATIONAHA.106.641225","volume":"114","author":"Oral","year":"2006","unstructured":"Oral H, Chugh A, \u00d6zaydin M et al (2006) Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation 114:759\u2013765","journal-title":"Circulation"},{"key":"46_CR25","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/eurheartj\/ehl364","volume":"28","author":"Perez-Gomez","year":"2007","unstructured":"Perez-Gomez F, Iriarte JA, Zumalde J et al (2007) Antithrombotic therapy in elderly patients with atrial fibrillation: effects and bleeding complications: a stratified analysis of the NASPEAF randomized trial. Eur Heart J 28:996\u20131003","journal-title":"Eur Heart J"},{"key":"46_CR26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","volume":"I","author":"Petersen","year":"1989","unstructured":"Petersen P, Boysen G, Godtfredsen J et al (1989) Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet I:175\u2013179","journal-title":"Lancet"},{"key":"46_CR27","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1161\/01.CIR.93.6.1262","volume":"93","author":"Prystowsky","year":"1996","unstructured":"Prystowsky EN, Benson DW, Fuster V et al (1996) Management of patients with atrial fibrillation. A statement for Healthcare Professionals from the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation 93:1262\u20131277","journal-title":"Circulation"},{"key":"46_CR28","doi-asserted-by":"crossref","unstructured":"Rash A, Downes T, Portner R et al (2007) A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO) Age Aging 36:151\u2013156","DOI":"10.1093\/ageing\/afl129"},{"key":"46_CR29","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jacc.2004.11.050","volume":"45","author":"Senatore","year":"2005","unstructured":"Senatore G, Stabile G, Bertaglia E et al (2005) Role of transtelephonic electrocardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation. J Am Coll Cardiol 45:873\u2013876","journal-title":"J Am Coll Cardiol"},{"key":"46_CR30","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1161\/01.CIR.0000120509.64740.DC","volume":"109","author":"Stellbrink","year":"2004","unstructured":"Stellbrink C, Nixdorff U, Hofmann T et al (2004) Safety and efficacy of enoxaparin compared with unfrationated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial. Circulation 109:997\u20131003","journal-title":"Circulation"},{"key":"46_CR31","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/01.CIR.84.2.527","volume":"84","author":"Stroke","year":"1991","unstructured":"Stroke Prevention in Atrial Fibrillation Study (1991) Final results. Circulation 84:527\u2013539","journal-title":"Circulation"},{"key":"46_CR32","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1093\/eurheartj\/ehi306","volume":"26","author":"Testa","year":"2005","unstructured":"Testa L, Biondi-Zoccai GGL, Russo AD et al (2005) Rate-control vs. rhythm-control in patients with atrial fibrillation: a meta-analysis. Eur Heart J 26:2000\u20132006","journal-title":"Eur Heart J"},{"key":"46_CR33","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","volume":"367","author":"The","year":"2006","unstructured":"The ACTIVE writing group on behalf of the ACTIVE investigators (2006) Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet 367:1903\u20131912","journal-title":"Lancet"},{"key":"46_CR34","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1056\/NEJM199011293232201","volume":"323","author":"The","year":"1990","unstructured":"The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators (1990) The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 323:1505\u20131511","journal-title":"N Engl J Med"},{"key":"46_CR35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/eurheartj\/ehm575","volume":"29","author":"Turpie","year":"2008","unstructured":"Turpie AGG (2008) New oral anticoagulants in atrial fibrillation. Eur Heart J 29:155\u2013165","journal-title":"Eur Heart J"},{"key":"46_CR36","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/archinte.163.8.936","volume":"163","author":"van","year":"2003","unstructured":"van Walraven WC, Hart RG, Wells GA et al (2003) A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin. Arch Intern Med 163:936\u2013943","journal-title":"Arch Intern Med"},{"key":"46_CR37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s003920170017","volume":"90","author":"Vetter","year":"2001","unstructured":"Vetter S, Ullmann HM, Lauke G, Volkmann H (2001) Besonderheiten der Thromboembolieprophylaxe bei betagten Patienten mit Vorhofflimmern. Z Kardiol 90(Suppl 5):105","journal-title":"Z Kardiol"},{"key":"46_CR38","first-page":"I","volume":"Cardiol","author":"Volkmann","year":"2008","unstructured":"Volkmann H, Bergmann C, Walter M (2008) Antikoagulation und Antiarrhythmika nach Vorhofflimmerablation. Clin Res Cardiol (Suppl 3):I\/118\u2013I\/123","journal-title":"Clin Res"},{"key":"46_CR39","first-page":"18","volume":"92","author":"Volkmann","year":"2003","unstructured":"Volkmann H, Vetter S, Spenke S et al (2003) Geschlechtsspezifische Unterschiede der Thromboembolieprophylaxe bei chronischem Vorhofflimmern im klinischen Alltag. Z Kardiol 92(Suppl 2):18","journal-title":"Z Kardiol"},{"key":"46_CR40","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","volume":"22","author":"Wolf","year":"1991","unstructured":"Wolf PA, Abbott AD, Kannell WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 22:983\u2013988","journal-title":"Stroke"},{"key":"46_CR41","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.hrthm.2006.12.001","volume":"4","author":"Wyse","year":"2007","unstructured":"Wyse DG (2007) Anticoagulation in atrial fibrillation: A contemporary viewpoint. Heart Rhythm 4:S35\u2013S39","journal-title":"Heart Rhythm"},{"key":"46_CR42","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","volume":"347","author":"Wyse","year":"2002","unstructured":"Wyse DG, Waldo AL, DiMarco JP et al (2002) A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347:1825\u20131833","journal-title":"N Engl J Med"}],"container-title":["Herzschrittmachertherapie + Elektrophysiologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-009-0046-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00399-009-0046-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-009-0046-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T05:45:11Z","timestamp":1559195111000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00399-009-0046-5"}},"subtitle":["Wann orale Antikoagulanzien? Wann Aspirin? Wann Heparine? Wann Kombinationen?"],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["46"],"URL":"https:\/\/doi.org\/10.1007\/s00399-009-0046-5","relation":{},"ISSN":["0938-7412","1435-1544"],"issn-type":[{"value":"0938-7412","type":"print"},{"value":"1435-1544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}